PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Cagliari, Italy.\', \'Department of Biomedical Sciences, University of Sassari, Sassari, Italy.\', \'Regional Multiple Sclerosis Center, Azienda SocioSanitaria Locale (ASSL) Cagliari, Azienda Tutela Salute (ATS) Sardegna, Cagliari, Italy.\', \'Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.\', \'Department of Biomedical Sciences, University of Sassari - Unit of Clinical Microbiology, Azienza Ospedaliera Universitaria (AOU) Sassari, Sassari, Italy.\', \'Department of Medical, Surgical and Experimental Sciences, University of Sassari - Neurology Unit, Azienza Ospedaliera Universitaria (AOU) Sassari, Sassari, Italy.\', \'Osservatorio Epidemiologico Veterinario Regionale, Istituto Zooprofilattico Sperimentale della Sardegna, Cagliari, Italy.\', \'Dipartimento di Medicina Traslazionale e di Precisione, Università la Sapienza, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.781843
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34956211
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all